Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response.
about
Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expressionDeletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy.Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cellsGenetic variability in the regulation of the expression cluster of MDR genes in patients with breast cancer.β3-tubulin is a good predictor of sensitivity to taxane-based neoadjuvant chemotherapy in primary breast cancer.VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
P2860
Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Changing the expression vector ...... djuvant chemotherapy response.
@en
Changing the expression vector ...... djuvant chemotherapy response.
@nl
type
label
Changing the expression vector ...... djuvant chemotherapy response.
@en
Changing the expression vector ...... djuvant chemotherapy response.
@nl
prefLabel
Changing the expression vector ...... djuvant chemotherapy response.
@en
Changing the expression vector ...... djuvant chemotherapy response.
@nl
P2093
P2860
P50
P1476
Changing the expression vector ...... adjuvant chemotherapy response
@en
P2093
Elena M Slonimskaya
Evgeny Y Garbukov
Marina K Merzliakova
Victor V Volkomorov
P2860
P2888
P304
P356
10.1007/S00280-012-1992-X
P50
P577
2012-10-02T00:00:00Z
P5875
P6179
1026255720